4.5 Review

The Use of Medical Marijuana in Cancer

期刊

CURRENT ONCOLOGY REPORTS
卷 18, 期 7, 页码 -

出版社

SPRINGER
DOI: 10.1007/s11912-016-0530-0

关键词

Marijuana; Cannabis; Cancer; Delta-9-tetrahydrocannabinol; Delta-9-THC; Tetrahydrocannabinol; THC; Cannabinoid; Cannabidiol; CBD; Endocannabinoid; Oncology; Dronabinol; Nabilone; Nabiximols

类别

向作者/读者索取更多资源

The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking. Medical marijuana is now legal, on some level, in 24 states plus the District of Columbia, yet is not legal on the federal level. This review addresses the current state of the research, including potential indications, risks and adverse effects, preliminary data on anticancer effects, as well as legal and quality issues. A summary of the clinical trials underway on medical marijuana in the oncology setting is discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据